Leutetium-PMSA is a type of targeted therapy that delivers radiation to prostate cancer sparing normal healthy cells.  It works by combining radioactive particles to a “homing” protein, the seeks out prostate cancer cells.

When the medication is injected into the bloodstream, this medication will travel to the prostate cancer cells wherever they may be in the body, and deliver a high dose of radiation.